MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Cytosorbents Corporation Total Liabilities 2011-2026 | CTSO
Annual Total Liabilities Cytosorbents Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.3 M | 36.3 M | 29.5 M | 27.9 M | 26.9 M | 10.7 M | 24 M | 15.8 M | 13.8 M | 10.2 M | 3.04 M | 4.51 M | 18.3 M | 15 M | 1.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.3 M | 1.8 M | 18.4 M |
Quarterly Total Liabilities Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.7 M | 36.4 M | 36.2 M | 36.3 M | 34.8 M | 36.7 M | 28.1 M | 30 M | 29.1 M | 28.4 M | 28.5 M | 27.9 M | 23.1 M | - | 27.8 M | 26.9 M | 24.5 M | 23.8 M | 10.2 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 24 M | 24 M | 24 M | 24 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 8.36 M | 8.36 M | 10.2 M | 10.2 M | 3.04 M | 3.04 M | 3.04 M | - | - | - | - | - | 3.06 M | 3.07 M | 2.1 M | 993 K | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 36.7 M | 993 K | 16.2 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 13.08 | 2.19 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 63.41 | -1.23 % | $ 3.46 B |  Britain |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.21 | 2.36 % | $ 62.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 188.31 | -0.66 % | $ 13.2 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
27.2 M | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.21 | -4.84 % | $ 317 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 93.7 | -1.23 % | $ 12.7 B | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.35 | -4.86 % | $ 6.52 M | USA |
 |
Helius Medical Technologies
HSDT
|
5.34 M | - | - | $ 1.28 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 26.0 | -1.48 % | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Stryker Corporation
SYK
|
25.4 B | $ 329.01 | 0.46 % | $ 126 B | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.82 | -2.29 % | $ 371 M | USA |
 |
Butterfly Network
BFLY
|
87.2 M | $ 5.48 | 2.81 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.84 | - | $ 388 M | USA |
 |
Varex Imaging Corporation
VREX
|
621 M | $ 12.71 | 1.44 % | $ 526 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.08 | 1.89 % | $ 18.3 M | USA |
 |
Vivos Therapeutics
VVOS
|
26.7 M | $ 0.86 | 2.46 % | $ 8.84 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | - | - | $ 1.18 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 55.07 | -2.2 % | $ 1.62 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 85.35 | -0.78 % | $ 2.96 B | USA |
 |
PAVmed
PAVM
|
16.5 M | $ 8.4 | -6.67 % | $ 5.63 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 83.46 | -0.82 % | $ 48.8 B | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.34 | -2.62 % | $ 494 M | USA |